Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Small Cell Carcinoma of Lung”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05492682
What this trial is testing

START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer

Who this might be right for
Melanoma (Skin)Triple-Negative Breast CancerNon-Small Cell Lung Cancer+5 more
Valo Therapeutics Oy 15
Not applicableStudy completedNCT03948724
What this trial is testing

Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology

Who this might be right for
Therapeutic Patient EducationImmune Checkpoint InhibitorsMelanoma+4 more
Institut Cancerologie de l'Ouest 412
Not applicableUnknownNCT03424980
What this trial is testing

Evaluate Effectiveness and Safety of Tyrosine Kinase Inhibitors

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Tang-Du Hospital 200
Testing effectiveness (Phase 2)Study completedNCT01498562
What this trial is testing

Phase II Study of Gefitinib Plus Nimotuzumab Versus Gefitinib in Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
Yonsei University 160
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07746388
What this trial is testing

Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE Trial

Who this might be right for
NsclcNSCLC Stage IINSCLC, Stage III+2 more
University of Maryland, Baltimore 30
Early research (Phase 1)Ended earlyNCT02199886
What this trial is testing

Dose-escalation Study of BIBH 1 in Patients With Non-small Cell Lung Cancer Scheduled for Surgical Resection

Who this might be right for
Lung Neoplasms
Boehringer Ingelheim 6
Early research (Phase 1)Study completedNCT03538028
What this trial is testing

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Who this might be right for
Cervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more
Incyte Biosciences International Sàrl 22
Not applicableUnknownNCT04858828
What this trial is testing

Investigation on Predictive Molecular Markers of Efficacy for Front-line Immunochemotherapy in Advanced NSCLC

Who this might be right for
Biomarkers
Zhou Chengzhi 200
Testing effectiveness (Phase 2)Study completedNCT02392507
What this trial is testing

Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC

Who this might be right for
Carcinoma, Non-Small Cell Lung Cancer (NSCLC)
Eli Lilly and Company 54
Large-scale testing (Phase 3)Not Yet RecruitingNCT05767892
What this trial is testing

YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

Who this might be right for
Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Suzhou Puhe Pharmaceutical Technology Co., LTD 350
Early research (Phase 1)Study completedNCT02668393
What this trial is testing

Nintedanib and Weekly Docetaxel in Lung Adenocarcinoma

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 14
Not applicableActive Not RecruitingNCT05382052
What this trial is testing

Study of ctDNA as Prognostic Factor on Resectable Stage IIIA NSCLC Patients Treated With Neoadjuvant Treatment

Who this might be right for
Non Small Cell Lung Cancer Stage IIINeoadjuvant Treatment
Fundación GECP 100
Early research (Phase 1)UnknownNCT05369312
What this trial is testing

Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients

Who this might be right for
Solid TumorNon-small Cell Lung CancerPancreatic Cancer+1 more
Betta Pharmaceuticals Co., Ltd. 230
Not applicableNot Yet RecruitingNCT06813144
What this trial is testing

Effectiveness of Respiratory Muscle Training with a Mobile Application After Lobectomy

Who this might be right for
Video Assisted Thoracic Surgery (VATS)Thoracic SurgeryRespiratory Muscle+1 more
Hacettepe University 45
Testing effectiveness (Phase 2)Ended earlyNCT02132598
What this trial is testing

Trial of Cabozantinib (XL184) in Non-Small Cell Lung Cancer With Brain Metastases

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)Metastases to the Brain
Liza Villaruz, MD 5
Testing effectiveness (Phase 2)Ended earlyNCT01313663
What this trial is testing

Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population

Who this might be right for
Lung Cancer, Small Cell
GlaxoSmithKline 20
Testing effectiveness (Phase 2)Study completedNCT01708993
What this trial is testing

Reolysin in Previously Treated Advanced/Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage Therapy

Who this might be right for
Non Small Cell Lung Cancer
Canadian Cancer Trials Group 166
Large-scale testing (Phase 3)Active Not RecruitingNCT05170204
What this trial is testing

A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 68
Testing effectiveness (Phase 2)UnknownNCT02815007
What this trial is testing

Chidamide With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer

Who this might be right for
Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer
Yuankai Shi 20
Not applicableUnknownNCT00385164
What this trial is testing

The Utility of FDG-PET for Radiation Treatment in NSCLC

Who this might be right for
Lung NeoplasmsPositron Emission Tomography
AHS Cancer Control Alberta 50
Next Page